← Leaderboards
Darrell M Wilson
Stanford University
$9,493,607
Attributed
$9,493,607
Total exposure
27
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–18$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$9,493,607 · 27
By mechanism
U01$8,477,948 · 1
M01$698,970 · 25
U10$316,689 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Michael L Whitfield$14,056,386
- Michelle Louise James$4,919,512
- Oscar Salvatierra$7,752,493
- Edgar G. Engleman$35,389,843
- Ronald Levy$27,846,042
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsInsulinClinical ResearchDiabetes MellitusHuman SubjectRandomizedPreventionPreventInsulin Dependent Diabetes MellitusAdolescentChildHuman Therapy EvaluationFundingEnrollmentGrantUnited States National Institutes Of HealthResearch PersonnelResourcesSourceComputer Retrieval Of Information On Scientific Projects DatabaseInstitutionMediatingUniversitiesDisease /Disorder Prevention /Control
Grant awards (55)
TrialNet at Stanford University$532,743
U01 · FY2018 · DK · contact PI
TrialNet at Stanford University$493,547
U01 · FY2017 · DK · contact PI
TrialNet at Stanford University$493,547
U01 · FY2016 · DK · contact PI
TrialNet at Stanford University$493,547
U01 · FY2015 · DK · contact PI
TrialNet at Stanford University$493,589
U01 · FY2014 · DK · contact PI
Type 1 Diabetes TrialNet at Stanford$15,164
U01 · FY2014 · DK · contact PI
Type 1 Diabetes TrialNet at Stanford$657,024
U01 · FY2013 · DK · contact PI
Type 1 Diabetes TrialNet at Stanford$536,530
U01 · FY2012 · DK · contact PI
Type 1 Diabetes TrialNet at Stanford$525,436
U01 · FY2011 · DK · contact PI
Type 1 Diabetes TrialNet at Stanford$553,480
U01 · FY2010 · DK · contact PI
Type 1 Diabetes TrialNet at Stanford$437,882
U01 · FY2009 · DK · contact PI
CLINICAL TRIAL: TRIALNET SCREENING TO ASSESS RISK OF TYPE 1 DIABETES$7,964
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: RITUXIMAB ON THE PROGRESSION OF TYPE 1 DIABETES IN NEW ONSET SUB$6,713
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: TYPE 1 DIABETES: CELLCEPT ALONE OR IN COMBINATION WITH DACLIZUMA$5,461
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: TRIAL OF METFORMIN IN OBESE ADOLESCENTSMETFORMIN IN OBESE ADOL$1,479
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: SHARED DIABETES TRIAL STUDIES$796
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: ORAL INSULIN IN RELATIVES AT RISK FOR TYPE I DIABETES MELLITUS$455
M01 · FY2008 · RR · contact PI
Type 1 Diabetes TrialNet at Stanford$935,273
U01 · FY2007 · DK · contact PI
TYPE 1 DIABETES: CELLCEPT ALONE OR IN COMBINATION WITH DACLIZUMAB$55,003
M01 · FY2007 · RR · contact PI
TRIALNET SCREENING TO ASSESS RISK OF TYPE 1 DIABETES$33,353
M01 · FY2007 · RR · contact PI
TRIAL OF METFORMIN IN OBESE ADOLESCENTS$21,065
M01 · FY2007 · RR · contact PI
SHARED DIABETES TRIAL STUDIES$4,682
M01 · FY2007 · RR · contact PI
RECENT ONSET TYPE-1 DIABETES MELLITUS STUDY OF USING FRESH BLOOD SAMPLES$1,171
M01 · FY2007 · RR · contact PI
EFFECTS OF RITUXIMAB ON THE PROGRESSION OF TYPE 1 DIABETES$585
M01 · FY2007 · RR · contact PI
Type I Diabetes Trialnet at Stsnford$183,093
U01 · FY2006 · DK · contact PI
METFORMIN IN OBESE ADOLESCENTS$31,134
M01 · FY2006 · RR · contact PI
IMPROVING METABOLIC ASSESSMENTS IN TYPE-1 DIABETES MELLITUS CLINICAL TRIALS$25,797
M01 · FY2006 · RR · contact PI
IMMUNOTHERAPY FOR NEW ONSET TYPE-1 DIABETES$23,128
M01 · FY2006 · RR · contact PI
TRIALNET SCREENING TO ASSESS RISK OF TYPE-1 DIABETES$14,233
M01 · FY2006 · RR · contact PI
BLOOD SAMPLES FROM SUBJECTS WITH RECENT ONSET TYPE-1 DIABETES MELLITUS$8,896
M01 · FY2006 · RR · contact PI
SHARED DIABETES TRIAL STUDIES$8,006
M01 · FY2006 · RR · contact PI
Type I Diabetes Trialnet at Stsnford$771,086
U01 · FY2005 · DK
Type I Diabetes Trialnet at Stsnford$72,564
U01 · FY2005 · DK
METFORMIN IN OBESE ADOLESCENTS$18,711
M01 · FY2005 · RR
SHARED DIABETES TRIAL STUDIES$10,023
M01 · FY2005 · RR
IMMUNOTHERAPY FOR NEW ONSET TYPE 1 DIABETES$5,680
M01 · FY2005 · RR
TRIALNET SCREENING TO ASSESS RISK OF TYPE 1 DIABETES$1,671
M01 · FY2005 · RR
A DIABETES PREVENTION TRIAL FOR TYPE I DIABETES [DPT-1]$334
M01 · FY2005 · RR
Type I Diabetes Trialnet at Stsnford$333,926
U01 · FY2004 · DK
Multicenter Intervention Trial to Prevent IDD$6,519
M01 · FY2004 · RR
A Multi-center, Randomized, Placebo-Controlled$1,185
M01 · FY2004 · RR
Shared Diabetes Trial Studies$296
M01 · FY2004 · RR
Type I Diabetes Trialnet at Stsnford$322,200
U01 · FY2003 · DK
Type I Diabetes Trialnet at Stsnford$321,767
U01 · FY2002 · DK
Near-Continuous Glucose Monitoring in Pediatrics$316,689
U10 · FY2001 · HD
Type I Diabetes Trialnet at Stanford$305,550
U01 · FY2001 · DK
INTENSIVE INSULIN REGIMEN FOR TYPE I DIABETES MELLITUS$134,676
M01 · FY2001 · RR
MULTICENTER INTERVENTION TRIAL TO PREVENT INSULIN-DEPENDENT DIABETES MELLITUS$134,676
M01 · FY2001 · RR
IMPROVED MONITORING OF GNRH ANALOG THERAPY$134,676
M01 · FY2001 · RR
MULTICENTER INTERVENTION TRIAL TO PREVENT INSULIN-DEPENDENT DIABETES MELLITUS$0
M01 · FY2001 · RR
IMPROVED MONITORING OF GNRH ANALOG THERAPY$0
M01 · FY2001 · RR
INTENSIVE INSULIN REGIMEN FOR TYPE I DIABETES MELLITUS$0
M01 · FY2001 · RR
MULTICENTER INTERVENTION TRIAL TO PREVENT INSULIN-DEPENDENT DIABETES MELLITUS$602
M01 · FY2000 · RR
IMPROVED MONITORING OF GNRH ANALOG THERAPY$0
M01 · FY2000 · RR
INTENSIVE INSULIN REGIMEN FOR TYPE I DIABETES MELLITUS$0
M01 · FY2000 · RR